— US-based pharma indications deal with generic business in South Asia to disperse and make drug United States-based pharmaceutical company Gilead has actually gotten in a non-exclusive licencing arrangement with 5 South Asian companies, consisting of Ferozsons Laboratories, for the production and circulation of Remdesivir to 127 countries. The drug is being evaluated as a […]

The post Covid-19: Gilead inks deal with Feronzsons for Remdesivir appeared first on World Weekly News.